Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market ...

OrganiGram Holdings ( ($OGI) ) has released its Q3 earnings. Here is a breakdown of the information OrganiGram Holdings presented to its ...

Organigram's Q3 sales rose 72% to $51.14 million, driven by Motif acquisition and global demand, with margin gains and positive cash flow expected.

Reports Q3 adjusted EBITDA $5.694M vs. $3.465M. “In Q3, we delivered our second consecutive quarter of record revenue driven by the acquisition of ...

TORONTO (AP) — TORONTO (AP) — Organigram Global Inc. (OGI) on Wednesday reported a loss of $4.5 million in its fiscal third quarter. On a per-share basis, the Toronto-based company said it had a loss ...

Analysts expect OrganiGram Holdings to report an earnings per share (EPS) of $-0.01. The announcement from OrganiGram Holdings is eagerly anticipated, with investors seeking news of surpassing ...

OrganiGram’s revenue growth is very impressive. With plenty of cash in hand, in my view, the company’s acquisitions and further product development will likely serve as revenue catalysts.

Organigram to supply Israeli pharmaceutical grade cannabis leader InterCure with up to 20,000 kg of dried flower over multiple yearsTORONTO and HERZILA, Israel, Nov. 17, 2022 (GLOBE NEWSWIRE ...

Accelerates Organigram’s R&D and product pipeline development, provides meaningful capital injection of ~C$221 million and strengthens Organigram’s ability to compete in existing markets and ...

At the very end of 2023, I explained why Organigram (NASDAQ: OGI) was my favorite cannabis stock. It still is! The stock is up a lot this year, and my ownership in my model portfolio of a 19.5% ...

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.